Latest filing published 30 Nov 2018 for Arbutus Biopharma Corp, €30k.
Insider track record
Mark J. Murray: trading record in brief
Mark J. Murray discloses dealings in Arbutus Biopharma Corp to SEC (Form 4). We count 4 filings; the first trade dates from 11 September 2015 and the latest from 28 November 2018.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 30 November 2018 with an option exercise (€30k) in Arbutus Biopharma Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark J. Murray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$1.3579.4% of flowCommon SharesSEC:0001123292-18-001091:0
- 27,007 shares@ US$0.35415.8% of flowCommon SharesSEC:0001140361-18-018863:0
- 5,000 shares@ US$2.5723.3% of flowCommon SharesSEC:0001140361-16-070360:0
- 219,428 shares@ US$0.4444Common SharesSEC:0001140361-15-035079:0
4 of 4 declarations
